Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PRDM12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
UBE2D4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EPN2-AS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
FXR2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ISYNA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AIM1L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GRB10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
COA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TPTE2P5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GIMAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC23A2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KRTAP5-8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMPRSS6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CARD11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
APMAP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CTU2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on